NextCell Pharma is an innovative Biotech growing out of the need for Advanced Therapy Medicinal Products for Autoimmune Disease and Transplantation. Cellaviva, the first Swedish family saving stem cell bank, with its expertise in umbilical cord stem cells and Diamyd Medical with its interests and investments within autoimmune diseases made a natural partnership for creating NextCell Pharma. Clinical trials testing NextCell Pharma’s first product, ProTrans,has started in Novermber 2018. #nextcellpharma #cellaviva
| Website | http://www.nextcellpharma.com |
| Revenue | $6 million |
| Employees | 15 (12 on RocketReach) |
| Founded | 2014 |
| Address | 7 Hälsovägen, Huddinge, Stockholm County 14157, SE |
| Phone | +46 8 735 55 95 |
| Technologies |
JavaScript
,
HTML
,
Twitter
+10 more
(view full list)
|
| Industry | Biotechnology Research, Manufacturing General, Manufacturing |
| Competitors | Sanofi, アステラス製薬(株), Kite Pharma, bluebird bio, Atara Biotherapeutics, Fate Therapeutics Inc, Mesoblast Limited, Cynata Therapeutics, Cellerant Therapeutics, TiGenix +52 more (view full list) |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies |
Looking for a particular NextCell Pharma AB employee's phone or email?
The NextCell Pharma AB annual revenue was $6 million in 2026.
Mathias Svahn is the CEO of NextCell Pharma AB.
12 people are employed at NextCell Pharma AB.
NextCell Pharma AB is based in Huddinge, Stockholm County.
The NAICS codes for NextCell Pharma AB are [32, 325, 32541, 3254].
The SIC codes for NextCell Pharma AB are [28, 283].